PANBELA THERAPEUTICS INVESTOR ALERT - Kuznicki Law PLLC Investigates Panbela Therapeutics, Inc. - PBLABusiness Wire • 05/04/22
Panbela Schedules Conference Call on May 12, 2022, to Report 2022 First Quarter Financial ResultsGlobeNewsWire • 04/26/22
PANBELA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Panbela Therapeutics, Inc. - PBLABusiness Wire • 04/07/22
Panbela Therapeutics Inc. (PBLA) CEO Jennifer Simpson on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/24/22
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial ResultsGlobeNewsWire • 03/24/22
Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 2022, at 12:00 pm ETGlobeNewsWire • 03/23/22
Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial ResultsGlobeNewsWire • 03/08/22
Panbela Therapeutics Acquires Cancer Prevention Pharmaceuticals For Stock & Milestone PaymentBenzinga • 02/22/22
PBLA Stock Investigation: Halper Sadeh LLP Is Investigating Whether the Merger of Panbela Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 02/22/22
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.GlobeNewsWire • 02/22/22
Panbela Initiates a Randomized, Double-Blind, Placebo-Controlled Study (ASPIRE) of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal AdenocarcinomaGlobeNewsWire • 01/26/22
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI MeetingGlobeNewsWire • 01/24/22
Panbela: Biotech With Updated Patent Protection And Unmet Market Target IndicationSeeking Alpha • 01/06/22
Panbela Announces Positive Preclinical Data Strongly Supporting the Activity of SBP-101 in Ovarian Cancer Cell Lines; Development Program for SBP-101's Expansion into Ovarian Cancer Expected in 1H 2022GlobeNewsWire • 12/14/21
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Gastrointestinal Cancers SymposiumGlobeNewsWire • 11/18/21
Panbela Therapeutics Inc. (PBLA) CEO Jennifer Simpson on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
Panbela Schedules Conference Call on November 10, 2021, to Report 2021 Third Quarter Financial ResultsGlobeNewsWire • 10/25/21
Panbela Therapeutics, Inc. (PBLA) CEO Jennifer Simpson on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/12/21
Panbela to Present at Access to Giving Virtual Conference on July 15, 2021, at 10:30 a.m. ETGlobeNewsWire • 07/07/21